Archive - April 2018
FDA Approves Tavalisse (fostamatinib disodium hexahydrate) for Chronic Immune Thrombocytopenia
FDA Approves Vonvendi [von Willebrand factor (recombinant)] for Perioperative Management of Bleeding in Adult Patients with von Willebrand Disease
The Creative Floor launch portfolio and jobs site
Amazon shelves plan to sell bulk pharmaceuticals
Two major lung cancer studies show promising results
The Smart Pharma Payoff
Product Focus: Avoiding a Mix-Up
AZ makes case for first-line Tagrisso therapy in lung cancer